Australia markets closed

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
20.88-0.38 (-1.79%)
At close: 03:00PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
1,068,195
1,166,498
1,035,724
791,231
1,062,181
Depreciation & amortisation
-
1,447,614
1,288,117
1,149,184
170,772
Change in working capital
-
-103,527
828,444
-878,473
495,248
Inventory
-
-104,163
-157,392
-745,925
-539,607
Other working capital
2,049,419
1,377,207
2,721,787
260,049
1,161,593
Other non-cash items
-
487,535
475,720
430,122
180,529
Net cash provided by operating activities
-
3,173,848
3,756,573
1,554,995
1,953,916
Cash flows from investing activities
Investments in property, plant and equipment
-1,598,665
-1,796,641
-1,034,787
-1,294,946
-792,323
Acquisitions, net
-463,869
-502,295
-305,249
-529,825
-289,751
Purchases of investments
-71,731
-104,016
-428,860
-1,637,987
-2,420,360
Sales/maturities of investments
-
104,687
451,643
2,471,095
2,421,841
Other investing activities
-
-19,632
-14,074
2,360
-3,000
Net cash used for investing activities
-2,130,378
-2,303,262
-1,293,951
-967,696
-1,071,242
Net change in cash
-21,217
-778,783
1,529,052
-1,024,668
2,091,708
Cash at beginning of period
3,569,294
3,776,206
2,247,153
3,271,822
1,180,113
Cash at end of period
3,548,077
2,997,423
3,776,206
2,247,153
3,271,822
Free cash flow
Operating cash flow
-
3,173,848
3,756,573
1,554,995
1,953,916
Capital expenditure
-1,598,665
-1,796,641
-1,034,787
-1,294,946
-792,323
Free cash flow
2,049,419
1,377,207
2,721,787
260,049
1,161,593